Prediction of Response to Trimodality Therapy Using CT-Derived Radiomic Features in Stage III Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Jain, P. [1 ]
Ahmad, U. [2 ]
Murthy, S. [2 ]
Stephans, K. [3 ]
Khorrami, M. [4 ]
Madabhushi, A. [4 ]
Velcheti, V. [1 ]
机构：
[1] Cleveland Clin, Pepper Pike, OH USA
[2] Cleveland Clin, Thorac & Cardiovasc Surg, Cleveland, OH 44106 USA
[3] Cleveland Clin, Radiat Oncol, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Biomed Engn, Cleveland, OH 44106 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
radiomics; non-small cell lung cancer; chemoradiation;
D O I：
10.1016/j.jtho.2017.09.617
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA 17.11
引用
收藏
页码：S1875 / S1875
页数：1
相关论文
共 50 条
  • [21] Multimodality therapy in stage III non-small cell lung cancer
    Edelman, MJ
    Gandara, DR
    Roach, M
    Benfield, JR
    ANNALS OF THORACIC SURGERY, 1996, 61 (05): : 1564 - 1572
  • [22] Trimodality therapy for locally advanced non-small cell lung cancer
    Lackner, R. P.
    Ganti, A.
    Zhen, W.
    Copur, M. S.
    Vaziri, I. A.
    Bolton, M.
    Hlavaty, T.
    Trujillo, K. P.
    Kessinger, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Chemoradiation in older patients with stage III non-small cell lung cancer (NSCLC)
    Ng, Dawn M.
    Sun, Alex
    Coate, Linda
    Ma, Clement
    Bezjak, Andrea
    Brade, Anthony
    Burkes, Ronald L.
    Cho, John
    Feld, Ronald
    Liu, Geoff
    Shepherd, Frances
    Leighl, Natasha B.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S858 - S858
  • [24] TARGETED THERAPY CHANGING NON-SMALL CELL LUNG CANCER PARADIGM: USE OF ALECTINIB IN STAGE III NSCLC
    Selene, Insija
    Hao, Zhonglin
    Jose, Jemin
    Veedu, Janeesh Sekkath
    CHEST, 2023, 164 (04) : 4304A - 4305A
  • [25] The value of combined modality therapy in elderly patients with stage III non-small cell lung cancer (NSCLC)
    Schild, S. E.
    Mandrekar, S. J.
    Jatoi, A.
    McGinnis, W. L.
    Stella, P. J.
    Deming, R. L.
    Jett, J. R.
    Garces, Y. I.
    Allen, K. L.
    Adjei, A. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] Chemotherapy and intensity modulated radiation therapy (IMRT) for stage III non-small cell lung cancer (NSCLC)
    Laser, B.
    Yorke, E. D.
    Jackson, A.
    Sura, S.
    Rosenzweig, K. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S429 - S429
  • [27] Stage III Non-small Cell Lung Cancer
    Rusch, Valerie W.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 37 (05) : 727 - 735
  • [28] Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC): Predictors of Surgical Drop Out
    Liriano, M.
    Nichols, E. M.
    Morris, C. G.
    Burrows, W.
    Battafarano, R. J.
    Garofalo, M. C.
    Turner, M.
    Suntharalingam, M.
    Edelman, M. J.
    Feigenberg, S. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S173 - S174
  • [29] Radiomic features of primary tumor by lung cancer stage: analysis in BRAF mutated non-small cell lung cancer
    Padole, Atul
    Singh, Ramandeep
    Zhang, Eric W.
    Mendoza, Dexter P.
    Dagogo-Jack, Ibiayi
    Kalra, Mannudeep K.
    Digumarthy, Subba R.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (04) : 1441 - 1451
  • [30] Proton therapy for early-stage non-small cell lung cancer (NSCLC)
    Gomez, Daniel R.
    Li, Heng
    Chang, Joe Y.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (02) : 199 - 204
12345